NYSE:HCA News 13 December 2025 - 28 January 2026

HCA Healthcare shares fell 2.8% to $491.72 Wednesday, erasing some of Tuesday’s 11% rally after earnings. The company set 2026 EPS guidance at $29.10–$31.50 and announced a $10 billion share buyback. Investors weighed cost cuts against risks from changes in ACA coverage and payer mix. Fourth-quarter revenue rose 6.7% to $19.51 billion, with net income up 30.6% to $1.88 billion.

HCA Healthcare shares jumped 7.4% to $507.50 Tuesday after the company raised its 2026 profit outlook and announced a $10 billion share buyback. Fourth-quarter revenue rose 6.7% to $19.51 billion, with adjusted earnings at $8.01 per share. HCA expects 2026 revenue between $76.5 billion and $80 billion, and earnings per share of $29.10 to $31.50. The board approved a quarterly dividend of $0.78 per share, payable March 31.

HCA Healthcare closed at $474.06 in a shortened Christmas Eve session, then slipped to $468.74 in after-hours trading, down 1.12%. Trading volume was about 250,000 shares, well below normal. U.S. stock markets will remain closed for Christmas Day and reopen Friday, Dec. 26, 2025. Policy uncertainty over ACA premium subsidies continues to weigh on the healthcare sector.

Updated: December 12, 2025 (U.S. market close)HCA Healthcare, Inc. (NYSE: HCA) closed Friday at $484.77, finishing the week essentially flat—but not quiet. A sharp midweek drop and quick rebound put policy risk, reimbursement headlines, and year-end positioning back in the spotlight for America’s largest for-profit hospital operator. StockAnalysis+2MarketWatch+2 Below is what moved HCA stock this week, the most important HCA Healthcare news from the past several days, what analysts are forecasting now, and the key catalysts to watch in the week ahead. HCA stock this week: flat finish, big intrawEEK volatility HCA ended Friday (Dec. 12) at $484.77, up 0.50%